Blood test markers in acute pancreatitis
Part of Digestive system clinical trials.
This study looks at whether routine blood tests can help predict how serious acute pancreatitis will be. It aims to find simple markers that may guide treatment and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a diagnosis of acute pancreatitis, confirmed by belly pain, high blood enzyme levels, or imaging.
- You must be admitted to the hospital within 3 days (72 hours) of symptoms starting.
- You cannot have chronic pancreatitis, a weakened immune system, or an active infection needing antibiotics at admission.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at specific blood “immune” signatures and how they relate to outcomes in people with acute pancreatitis. If you enroll early, it may help doctors better predict how the illness will go and identify who might need more care.
This study looks at people with sudden pancreas inflammation (acute pancreatitis) to see if certain factors can predict how well they recover. It may help doctors better understand your condition and plan your care.
This study looks at blood tests to find markers that may help detect and monitor pancreatic cancer. It compares people with pancreatic cancer to those with benign pancreatic conditions and healthy volunteers.
This trial looks at how severe acute pancreatitis works by using advanced tests on your body's germs, chemicals, and proteins. It may help find better ways to treat patients with this condition.
This study observes adults with acute pancreatitis to learn more about how the condition presents and what happens to patients over time. By participating, you can help researchers improve care for this painful condition.
This study looks at how the bacteria in your gut (microbiome) might affect the severity of a first-time acute pancreatitis attack. It aims to see if certain gut bacteria can predict how serious the illness will be, which could help doctors treat patients better.
Hear when a new Acute Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.